A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers

Healthy Elderly Volunteers Clinical Trial

Official title:
A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the single-dose plasma pharmacokinetics of LNK-754 as well as safety and tolerability in normal healthy male and female elderly volunteers

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Masking: Double-Blind

Related Conditions & MeSH terms

Healthy Elderly Volunteers

Clinical Trial Details

NCT number	NCT00903253
Study type	Interventional
Source	Link Medicine Corporation
Contact
Status	Completed
Phase	Phase 1
Start date	May 2009
Completion date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01215552` - Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712	Phase 1
Recruiting	`NCT03818802` - Effects of Vitamin B3 Derivative Nicotinamide Riboside (NR) in Bone, Skeletal Muscle and Metabolic Functions in Aging	N/A
Completed	`NCT01795339` - A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients	Phase 1
Completed	`NCT01739647` - A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects	Phase 1